Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyung Hoon Min

Showing results (171-180 of 189) with videos related to

Pageof 19
Sort By:
Clinical Biochemistry|January 28, 2014
Increased expression of vascular endothelial growth factor and hypoxia inducible factor-1α in lung tissue of patients with chronic bronchitisSeung Hyeun Lee, Sang Hoon Lee, Chul Hwan Kim, et al.
Cancer Research and Treatment|May 19, 2016
Reactive Oxygen Species Modulator 1 (Romo1) Predicts Poor Outcomes in Advanced Non-small Cell Lung Cancer Patients Treated with Platinum-Based ChemotherapySeung Hyeun Lee, Sue In Choi, Ji Sung Lee, et al.
Lung Cancer (Amsterdam, Netherlands)|December 4, 2014
Reactive oxygen species modulator 1 (Romo1) overexpression is an independent predictor of poor survival in NSCLC patients who undergo surgical resectionSeung Hyeun Lee, Joo Won Min, Ji Sung Lee, et al.
Bioorganic & Medicinal Chemistry Letters|December 4, 2003
Novel non-vanilloid VR1 antagonist of high analgesic effects and its structural requirement for VR1 antagonistic effectsYoung-Ger Suh, Yong-Sil Lee, Kyung-Hoon Min, et al.
Journal of Korean Medical Science|October 24, 2023
Empiric Anti-Pseudomonal β-Lactam Monotherapy Versus Fluoroquinolone Combination Therapy in Patients With Hospital-Acquired Pneumonia: A Multicenter Cohort Study With Propensity Score MatchingMoon Seong Baek, Ae-Rin Baek, Sang-Bum Hong, et al.
BMC Medical Ethics|July 17, 2023
Comparison of the end-of-life decisions of patients with hospital-acquired pneumonia after the enforcement of the life-sustaining treatment decision act in KoreaAe-Rin Baek, Sang-Bum Hong, Soohyun Bae, et al.
The Korean Journal of Internal Medicine|July 11, 2022
Microbiologic pattern and clinical outcome of non-ICU-acquired pneumonia: Korean HAP registry analysisJin Ho Jang, Hye Ju Yeo, Taehwa Kim, et al.
Lung|January 3, 2025
Impact of Multidrug-Resistant Bacterial Colonization on Clinical Characteristics, Antibiotic Treatment, and Clinical Outcomes of Hospital-Acquired PneumoniaJae Kyeom Sim, Kyung Hoon Min, Kwang Ha Yoo, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 9, 2010
A small molecule accelerates neuronal differentiation in the adult ratHeiko Wurdak, Shoutian Zhu, Kyung Hoon Min, et al.
Scientific Reports|September 16, 2022
Impact of nutrition and physical activity on outcomes of hospital-acquired pneumoniaJin Ho Jang, Taehwa Kim, Hye Ju Yeo, et al.
Pageof 19

Showing results (171-180 of 189) with videos related to

Sort By:
Pageof 19
Clinical Biochemistry|January 28, 2014
Increased expression of vascular endothelial growth factor and hypoxia inducible factor-1α in lung tissue of patients with chronic bronchitisSeung Hyeun Lee, Sang Hoon Lee, Chul Hwan Kim, et al.
Cancer Research and Treatment|May 19, 2016
Reactive Oxygen Species Modulator 1 (Romo1) Predicts Poor Outcomes in Advanced Non-small Cell Lung Cancer Patients Treated with Platinum-Based ChemotherapySeung Hyeun Lee, Sue In Choi, Ji Sung Lee, et al.
Lung Cancer (Amsterdam, Netherlands)|December 4, 2014
Reactive oxygen species modulator 1 (Romo1) overexpression is an independent predictor of poor survival in NSCLC patients who undergo surgical resectionSeung Hyeun Lee, Joo Won Min, Ji Sung Lee, et al.
Bioorganic & Medicinal Chemistry Letters|December 4, 2003
Novel non-vanilloid VR1 antagonist of high analgesic effects and its structural requirement for VR1 antagonistic effectsYoung-Ger Suh, Yong-Sil Lee, Kyung-Hoon Min, et al.
Journal of Korean Medical Science|October 24, 2023
Empiric Anti-Pseudomonal β-Lactam Monotherapy Versus Fluoroquinolone Combination Therapy in Patients With Hospital-Acquired Pneumonia: A Multicenter Cohort Study With Propensity Score MatchingMoon Seong Baek, Ae-Rin Baek, Sang-Bum Hong, et al.
BMC Medical Ethics|July 17, 2023
Comparison of the end-of-life decisions of patients with hospital-acquired pneumonia after the enforcement of the life-sustaining treatment decision act in KoreaAe-Rin Baek, Sang-Bum Hong, Soohyun Bae, et al.
The Korean Journal of Internal Medicine|July 11, 2022
Microbiologic pattern and clinical outcome of non-ICU-acquired pneumonia: Korean HAP registry analysisJin Ho Jang, Hye Ju Yeo, Taehwa Kim, et al.
Lung|January 3, 2025
Impact of Multidrug-Resistant Bacterial Colonization on Clinical Characteristics, Antibiotic Treatment, and Clinical Outcomes of Hospital-Acquired PneumoniaJae Kyeom Sim, Kyung Hoon Min, Kwang Ha Yoo, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 9, 2010
A small molecule accelerates neuronal differentiation in the adult ratHeiko Wurdak, Shoutian Zhu, Kyung Hoon Min, et al.
Scientific Reports|September 16, 2022
Impact of nutrition and physical activity on outcomes of hospital-acquired pneumoniaJin Ho Jang, Taehwa Kim, Hye Ju Yeo, et al.
Pageof 19